Position in DNLI
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,311
+$1,158 QoQ
Shares Held
51
+537.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#260
of 290 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $296,395 across 46 Biotechnology names. DNLI ranks #28 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 | |
| 2 | MRNA |
Moderna, Inc.
|
627 | $43,908 | |
| 3 | ARGX |
Argenx SE
|
36 | $33,399 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40 | $24,941 | |
| 5 | EXEL |
Exelixis, Inc.
|
293 | $15,942 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
56 | $13,494 | |
| 7 | INCY |
Incyte Corp
|
117 | $13,263 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
40 | $12,041 |
All Filings in DNLI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,311 | 51 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $153 | 8 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $132 | 8 | Shares | Sole | 2026-01-14 | |
| 2021-12-31 | $624 | 14 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||